Related Experiment Video
Updated: Apr 20, 2026
Laparoscopy-endoscopy Cooperative Surgery for the Treatment of Gastric Gastrointestinal Stromal Tumors
Published on: February 19, 2022
[Mesenchymal gastric tumor--not always GIST]
M Grosse-Holz1, M Sackmann, G Seitz
1Institut für Pathologie, Klinikum der Sozialstiftung Bamberg, Buger Str. 80, 96049, Bamberg, Deutschland, michaela.grosse-holz@sozialstiftung-bamberg.de.
Accurate classification of gastric schwannoma is vital. Differentiating it from gastrointestinal stromal tumors (GIST) impacts treatment, as schwannomas are benign and require less invasive surgery.
Area of Science:
- Gastrointestinal Pathology
- Surgical Oncology
- Diagnostic Imaging
Background:
- Accurate histopathological classification of gastric mesenchymal tumors is crucial for appropriate patient management.
- Distinguishing between schwannoma and gastrointestinal stromal tumors (GIST) has significant therapeutic implications.
Observation:
- Radiological and sonographical methods are insufficient for reliably differentiating gastric schwannoma from GIST.
- Schwannomas represent a definitively benign neoplasm, unlike GIST.
Findings:
- Histomorphological features are key to identifying gastric schwannoma.
- Immunohistochemical analysis provides essential data for definitive diagnosis.
Implications:
- Correctly identifying gastric schwannoma avoids unnecessary radical surgery such as (partial) gastrectomy.
- In sano (R0) resection is sufficient for treating gastric schwannoma.
- Precise histopathological and immunohistochemical characterization is paramount for optimal patient outcomes.
More Related Videos
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018